文献速递艾滋病与性传播感染

护士主导的HIV服药依从性干预:实效性与成本效果随机试验

Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.
PubMed 文献 · Lancet Infect Dis · 2017-03-03

该务实、多中心、开放标签随机对照试验在荷兰7家HIV门诊比较AIMS护士干预与常规治疗,纳入221例患者。

要点

  • 护士主导的AIMS干预可降低HIV患者病毒载量,优于常规依从性支持。
  • 推荐将AIMS纳入常规HIV临床护理实施。

核心结论

  • AIMS护士干预降低HIV患者病毒载量并增加QALYs,同时节省资源,推荐纳入常规HIV护理。

研究设计与样本

  • 荷兰7家HIV诊所的务实、多中心、开放标签随机对照试验,1:1随机分配至AIMS或常规治疗,按治疗经验分层并以护士为单位区组随机。
  • 意向性分析样本221例,AIMS组109例、常规治疗组112例,主要结局为第5、10、15月log10病毒载量。
  • 基于7347例荷兰HIV患者队列数据构建终身Markov模型,估算每QALY终身社会成本。

临床怎么用

  • 在常规HIV门诊由护士实施AIMS以改善服药依从性,可降低病毒载量并具成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No high-quality trials have provided evidence of effectiveness and cost-effectiveness of HIV treatment adherence intervention strategies. We therefore examined the effectiveness and cost-effectiveness of the Adherence Improving self-Management Strategy (AIMS) compared with treatment as usual. METHODS: We did a pragmatic, multicentre, open-label, randomised controlled trial in seven HIV clinics at academic and non-academic hospitals in the Netherlands. Eligible participants were patients with HIV who were either treatment experienced (ie, with ≥9 months on combination antiretroviral therapy [ART] and at risk of viral rebound) or treatment-naive patients initiating their first combination ART regimen. We randomly assigned participants (1:1) to either AIMS or treatment as usual (ie, containing a range of common adherence intervention strategies) using a computer-generated randomisation table. Randomisation was stratified by treatment experience (experienced vs naive) and included block randomisation at nurse level with randomly ordered blocks of size four, six, and eight. 21 HIV nurses from the participating clinics received three training sessions of 6 h each (18 h in total) on AIMS and a 1·5 h booster training session at the clinic (two to three nurses per session) after each nurse had seen two to three patients. AIMS was delivered by nurses during routine clinic visits. We did mixed-effects, intent-to-treat analyses to examine treatment effects on the primary outcome of log10 viral load collected at months 5, 10, and 15. The viral load results were exponentiated (with base 10) for easier interpretation. Using cohort data from 7347 Dutch patients with HIV to calculate the natural course of illness, we developed a lifetime Markov model to estimate the primary economic outcome of lifetime societal costs per quality-adjusted life-years (QALYs) gained. This trial is registered at ClinicalTrials.gov (number NCT01429142). FINDINGS: We recruited participants between Sept 1, 2011, and April 2, 2013; the last patient completed the study on June 16, 2014. The intent-to-treat sample comprised 221 patients; 109 assigned to AIMS and 112 to treatment as usual. Across the three timepoints (months 5, 10, and 15), log viral load was 1·26 times higher (95% CI 1·04-1·52) in the treatment-as-usual group (estimated marginal mean 44·5 copies per mL [95% CI 35·5-55·9]) than in the AIMS group (estimated marginal mean 35·4 copies per mL [29·9-42·0]). Additionally, AIMS was cost-effective (ie, dominant: cheaper and more effective) since it reduced lifetime societal costs by €592 per patient and increased QALYs by 0·034 per patient. INTERPRETATION: Findings from preparatory studies have shown that AIMS is acceptable, feasible to deliver in routine care, and has reproducible effects on medication adherence. In this study, AIMS reduced viral load, increased QALYs, and saved resources. Implementation of AIMS in routine clinical HIV care is therefore recommended. FUNDING: Netherlands Organisation for Health Research and Development.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. de Bruin M, Oberjé EJM, Viechtbauer W, et al. Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. Lancet Infect Dis. 2017. PMID: 28262598. doi:10.1016/S1473-3099(16)30534-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。